Is SNCAF a Buy or a Sell? The Bull and Bear Case (2026)

Last updated October 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for AtkinsRealis Group (SNCAF) rests on Nuclear build-out and CANDU: Nuclear revenue rose ~55% in 2025 to ~C$2.3 billion and grew another ~18% in the second quarter of 2026 to ~C$671 million, with segment adjusted EBIT up ~21%. The bear case rests on nuclear projects are long, politically dependent and exposed to delays, financing decisions and cost overruns. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

AtkinsRéalis Group Inc. (renamed from SNC-Lavalin in 2023) designs, engineers and manages infrastructure projects worldwide. The largest part of the business is Engineering Services Regions, ~C$7.5 billion of 2025 revenue, which earns fees for transport, water, buildings, defence and energy consulting across Canada, the UK, the US, Australia, Ireland and the Middle East. The Nuclear segment (~C$2.3 billion in 2025) services the global fleet of CANDU reactors, a design the company owns, supports refurbishments such as Bruce Power and Darlington, and is working on new builds such as Cernavoda 3 and 4 in Romania. Linxon (power substations) and a small Capital segment make up the rest. The company has exited the lump-sum turnkey construction contracts that caused years of losses. SNCAF is the same ordinary share as ATRL, quoted in US dollars one for one, not an ADR, so it tracks the Toronto price converted at the CAD/USD rate, with thinner OTC volume. The story has moved from turnaround to growth. Revenue reached ~C$11.0 billion in 2025, up 14%, adjusted EBITDA rose ~31% to ~C$979 million, and adjusted diluted EPS from the core services business jumped ~88% to ~C$3.36, led by a ~55% surge in nuclear revenue. In the second quarter of 2026 (reported August 6) revenue was ~C$3.0 billion, up 10% (8.3% organic), adjusted EBITDA hit a record ~C$293 million and adjusted diluted EPS was ~C$0.97 versus ~C$0.81. Management raised its 2026 nuclear revenue outlook to ~C$2.7 billion from ~C$2.5 billion. The 2025 sale of the last Highway 407 ETR stake produced an after-tax gain of ~C$2.2 billion and funded large buybacks. The debate is about how much growth is already priced in. Bulls point to a record ~C$13.4 billion Engineering Services backlog, rising global interest in nuclear power and a possible US entry for CANDU. Bears note that total backlog slipped to ~C$20.2 billion from ~C$21.2 billion at year end, nuclear backlog fell to ~C$4.2 billion from ~C$5.6 billion a year earlier, and regional engineering organic growth was only ~2% in the quarter because of Middle East disruption. SNCAF closed at ~US$61 on October 16, 2026, near the bottom of its ~US$57 to ~US$79 52-week range. Third-quarter results are scheduled for November 5, 2026.

The bull case for SNCAF

1. Nuclear build-out and CANDU

Nuclear revenue rose ~55% in 2025 to ~C$2.3 billion and grew another ~18% in the second quarter of 2026 to ~C$671 million, with segment adjusted EBIT up ~21%. Management raised its 2026 nuclear revenue outlook to ~C$2.7 billion and lifted its 2027 target range to ~C$2.6 to C$3.0 billion. The work spans refurbishments and life extensions in Ontario, new-build engineering for Cernavoda 3 and 4 in Romania and development of the larger CANDU MONARK design. In June 2026 the company filed a Notice of Intent with the US Nuclear Regulatory Commission to start licensing CANDU in the United States, an early step that would open a much larger market if it advances.

2. Engineering Services backlog and margins

Engineering Services Regions backlog reached a record ~C$13.4 billion at June 30, 2026, which gives visibility into recurring, lower-risk consulting fees. The segment's adjusted EBITDA margin on net revenue was ~16.4% in the second quarter, up from the 16.3% full-year 2025 level, against a 2026 target of 16.5% to 17.5%. Organic growth is the weaker part: it was only ~0.9% in 2025 and ~2% in the second quarter of 2026, though about 5% excluding the Asia, Middle East and Australia region. Management guided 2026 organic growth toward the low end of its 5% to 7% range, so the pace of recovery in that region matters for earnings.

3. Capital returns from the 407 proceeds

The 2025 Highway 407 ETR sale turned a decade-long infrastructure holding into cash, and the company returned ~C$939 million to shareholders through buybacks and dividends in 2025, including a large block repurchased from CDPQ. Repurchases continued in 2026, with ~C$242 million bought back in the second quarter and ~C$332 million returned in the first half. The share count has fallen to roughly 160 million from about 175 million before the program. Because the dividend is a token C$0.02 a quarter, buybacks are the main channel for returning cash, and continued repurchases lift per-share earnings even when revenue growth is modest.

4. Bolt-on acquisitions

The company has been buying regional engineering firms to fill gaps in fragmented markets. In 2025 it added David Evans (70% of a US engineering firm, with an option on the rest), C2AE and ADG, which expanded its North American footprint. In 2026 it announced WGA, Coras Solutions and TOBIN, deepening its presence in Australia and Ireland. Tuck-ins like these add revenue and local relationships without the risk of large construction contracts, and they partly offset slow organic growth in the Middle East. The tradeoffs are integration work, valuation discipline and the possibility that acquired growth masks softer organic performance in the core business.

The bear case for SNCAF

Nuclear projects are long, politically dependent and exposed to delays, financing decisions and cost overruns. Nuclear backlog fell to ~C$4.2 billion at June 30, 2026 from ~C$5.6 billion a year earlier as refurbishment work was burned off, so the segment needs new awards such as Cernavoda contracts or further Ontario work to sustain its pace, and the US CANDU licensing effort is at a very early stage. The company's history includes large losses on fixed-price construction contracts and past corruption cases (a 2019 guilty plea tied to Libya and a 2022 remediation agreement), so governance and contract discipline remain under scrutiny. The Middle East conflict has already cut regional organic growth to ~2%, and government infrastructure budgets in Canada and the UK can shift with elections. A union representing engineers in Canada has publicly pressed for a new contract. Currency moves between the Canadian dollar, pound and US dollar affect reported results and the US-dollar SNCAF quote. At roughly 23x trailing adjusted earnings, the valuation leaves less room for disappointment than at a typical engineering consultancy.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding SNCAF already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on SNCAF

Too few analysts publish on SNCAF for a consensus target to mean anything, so there is no professional average to weigh against your own view. That cuts both ways: less informed opinion to lean on, and less of it already priced in. The SNCAF forecast page covers what coverage does exist.

How is SNCAF valued? (as of October 2026)

Price
$60.68
Market cap
$9.71B
P/E (TTM)
30.96
Forward P/E
29.46
Price / book
2.57
Beta
0.93
52-week range
$56.68 to $78.58

Snapshot for SNCAF as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Revenue (TTM): ~C$11.7 billion
  • Revenue (FY2025): ~C$11.0 billion (+14%)
  • Adjusted diluted EPS (TTM): ~C$3.7
  • Market cap: ~US$9.8 billion
  • Share price (SNCAF, Oct 16, 2026): ~US$61
  • Total backlog (June 30, 2026): ~C$20.2 billion

At ~US$61 a share on the SNCAF line, the stock trades at roughly 23x trailing adjusted earnings of ~C$3.7 a share and about 22% below its ~US$79 52-week high. The trailing price-to-earnings ratio shown on quote screens is higher because it uses IFRS earnings, and reported net income comparisons are distorted by the ~C$2.2 billion Highway 407 gain in 2025, so adjusted figures from the core services business are the cleaner read. Company figures are in Canadian dollars; the SNCAF price and market cap are in US dollars.

How do you decide if SNCAF is a buy?

Rather than asking whether SNCAF is a buy in the abstract, it tends to help to answer four questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold SNCAF indirectly through an index or sector ETF before adding more.

What would change your mind on SNCAF

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Nuclear build-out and CANDU stalls in the reported numbers rather than in the narrative around them.
  • Bear case breaks if: nuclear projects are long, politically dependent and exposed to delays, financing decisions and cost overruns fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the SNCAF stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about SNCAF against your real portfolio and see your actual exposure before deciding.

Investing in AtkinsRealis Group with AI

Connect the broker you already use and ask Walnut's AI how SNCAF fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

Is SNCAF a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Nuclear build-out and CANDU, with revenue (ttm) at ~C$11.7 billion. The bear case rests on nuclear projects are long, politically dependent and exposed to delays, financing decisions and cost overruns. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell SNCAF?

+

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Nuclear projects are long, politically dependent and exposed to delays, financing decisions and cost overruns. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. Walnut is not an investment adviser.

What is the bull case for SNCAF?

+

Nuclear build-out and CANDU. Nuclear revenue rose ~55% in 2025 to ~C$2.3 billion and grew another ~18% in the second quarter of 2026 to ~C$671 million, with segment adjusted EBIT up ~21%.

What is the bear case for SNCAF?

+

Nuclear projects are long, politically dependent and exposed to delays, financing decisions and cost overruns. Nuclear backlog fell to ~C$4.2 billion at June 30, 2026 from ~C$5.6 billion a year earlier as refurbishment work was burned off, so the segment needs new awards such as Cernavoda contracts or further Ontario work to sustain its pace, and the US CANDU licensing effort is at a very early stage. The company's history includes large losses on fixed-price construction contracts and past corruption cases (a 2019 guilty plea tied to Libya and a 2022 remediation agreement), so governance and contract discipline remain under scrutiny. The Middle East conflict has already cut regional organic growth to ~2%, and government infrastructure budgets in Canada and the UK can shift with elections. A union representing engineers in Canada has publicly pressed for a new contract. Currency moves between the Canadian dollar, pound and US dollar affect reported results and the US-dollar SNCAF quote. At roughly 23x trailing adjusted earnings, the valuation leaves less room for disappointment than at a typical engineering consultancy.

What does AtkinsRealis Group do?

+

AtkinsRealis (formerly SNC-Lavalin) is a Montreal-based engineering and nuclear services firm; SNCAF is its US OTC line, while the primary listing trades on the TSX as ATRL.

What would have to change for SNCAF to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Nuclear build-out and CANDU) stalling in the reported numbers rather than in the narrative, the risk above (nuclear projects are long, politically dependent and exposed to delays, financing decisions and cost overruns) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What is SNCAF?

+

SNCAF is the US over-the-counter ticker for AtkinsRéalis Group Inc., the Canadian engineering and nuclear services company formerly called SNC-Lavalin. Its primary listing is ATRL on the Toronto Stock Exchange, where most of its trading volume and analyst coverage sit. The company is headquartered in Montreal and employs engineers, designers and project managers across Canada, the UK, the US, Australia, Ireland and the Middle East. Its two main businesses are Engineering Services Regions, which earned ~C$7.5 billion of revenue in 2025 from consulting and design fees, and Nuclear, which earned ~C$2.3 billion from servicing, refurbishing and building CANDU reactors. Total 2025 revenue was ~C$11.0 billion. SNCAF closed at ~US$61 on October 16, 2026, for a market value of ~US$9.8 billion.

How does SNCAF relate to ATRL on the TSX?

+

SNCAF is the same ordinary common share as ATRL, quoted in US dollars on the OTC market, one share for one share. It is not an ADR, so there is no depositary bank, ratio or ADR fee. Its price follows the Toronto price converted at the CAD/USD exchange rate, which means a US holder's return combines the stock's move in Canadian dollars with the currency move. OTC volume is much lower than on the TSX, so bid-ask spreads can be wider, especially outside Toronto trading hours. Some US brokers route orders to the TSX line directly for investors who prefer the deeper market. Dividends on either line are declared in Canadian dollars and are subject to Canadian withholding tax for non-residents, typically 15% under the US-Canada tax treaty.

Why did SNC-Lavalin change its name to AtkinsRéalis?

+

The company rebranded in September 2023, combining the Atkins name from the UK engineering firm it bought in 2017 with "Réalis", a nod to realizing projects. The new name marked a strategic break: management had already stopped bidding on lump-sum turnkey construction contracts, which produced large losses for years, and wanted to reposition the business as an engineering, nuclear and project management firm. It also marked a reputational reset after earlier corruption cases, including a 2019 guilty plea tied to work in Libya and a 2022 remediation agreement in Quebec. The Toronto ticker moved from SNC to ATRL, while the US OTC symbol stayed SNCAF. The legal entity, shares and history carried over unchanged, so the rebrand did not affect shareholders' holdings.

Walnut is informational, not investment advice, and gives no verdict on SNCAF. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.

The case for and against similar stocks